Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Melanoma 56 Carcinoma, Non-Small-Cell Lung 53 Carcinoma, Renal Cell 37 Lung Neoplasms 22 Neoplasm Metastasis 21 Carcinoma, Hepatocellular 21 Stomach Neoplasms 17 Squamous Cell Carcinoma of Head and Neck 17 Neoplasms 17 Colorectal Neoplasms 17 Carcinoma, Transitional Cell 14 Adenocarcinoma Of Esophagus 13 Prostatic Neoplasms 11 Hodgkin Disease 11 Brain Neoplasms 10 Urinary Bladder Neoplasms 9 Ovarian Neoplasms 8 Multiple Myeloma 8 Triple Negative Breast Neoplasms 7 Skin Neoplasms 7 Rectal Neoplasms 7 Pancreatic Neoplasms 7 Esophageal Neoplasms 7 Colonic Neoplasms 7 Clear-cell metastatic renal cell carcinoma 7 Breast Neoplasms 7 Sarcoma 6 Carcinoma, Merkel Cell 6 Carcinoma, Basal Cell 6 Uveal Melanoma 5

Interventions

Vinblastine 1 Nivolumab 1 Cyclophosphamide 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Childhood Solid Tumor × Nivolumab × 90 days × Clear all

NCT03585465 2026-05-29

Metro-PD1

Centre Oscar Lambret

Phase 1/2 Terminated

Other solid neoplasm

Childhood Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡